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A B S T R A C T
Today's growing interest in functional foods is due to their positive impacts on human health. The aim of this
study was to evaluate the probiotic properties and prebiotic metabolism of autochthonous lactic acid bacteria
from artisanal Serpa cheese. Twenty strains presented better tolerance to stress conditions found in the gas-
trointestinal tract, highlighting Lactobacillus brevis C1Lb21 for its adequate auto-aggregating ability and sig-
nificantly higher hydrophobicity. However, eight strains were discarded for their antibiotic resistance and
biogenic amine production. Finally, prebiotic fermentation study showed that lactulose supported better growth
of lactobacilli and induced the production of short-chain fatty acids (SCFA). During lactulose fermentation, Lb.
pentosus G4Lb7 produced statistically more SCFA, and Lb. plantarum G1Lb5 lactic acid. Thus, Lb. brevis C1Lb21,
Lb. plantarum G1Lb5 and Lb. pentosus G4Lb7 are promising probiotic candidates, and in combination with lac-
tulose could be used for developing a symbiotic cheese.
1. Introduction
Nowadays, there is a growing interest in nutrition to improve
health. Food is not only intended to provide the necessary nutrients but
also to beneficially impact on consumers’ health (Linares et al., 2017).
This matter has increased the awareness and demand for functional
food, mainly probiotics, due to the extensive information about their
beneficial effects. Lactic acid bacteria (LAB) are the most common
microorganisms applied as probiotics. They are a desirable member of
the gastrointestinal tract (GIT) microbiota and have the GRAS “Gen-
erally Recognised As Safe” status (Linares et al., 2017). Several LAB
species have shown probiotic characteristics and it is well-known that
they are strain-dependent (Vasiljevic & Shah, 2008). Fermented dairy
products have been by far the most investigated as a source of pro-
biotics.
Serpa cheese is a soft-cheese produced in the south of Portugal. In
our previous research, the microbial community of this artisanal cheese
have been described (Gonçalves Dos Santos, Benito, Córdoba,
Alvarenga, & Ruiz-Moyano, 2017; Gonçalves Dos Santos et al., 2018)
and LAB were undoubtedly the main microbial group, with viable
counts of around 108 cfu g−1 at the end of the ripening process. LAB are
involved in the ripening process of the cheese and contribute to the
final organoleptic properties (O'Sullivan & Cotter, 2017). Additionally,
the LAB strains present in Serpa cheese may possess probiotic potential.
The primary criteria for selecting strains as suitable probiotics are
(i) survival to GIT conditions, (ii) ability to adhere to the intestinal
mucosa and colonise the colon, at least temporarily, (iii) capacity to
exert potential health benefits on the host, and (iv) verified safety.
Another important activity of probiotics is the fermentation of non-di-
gestible carbohydrates into short-chain fatty acids (SCFA), mainly
acetate, propionate and butyrate. There is a plethora of evidence re-
garding the positive benefits of these compounds on human energy
metabolism, health and protection against colorectal cancer, in-
flammatory bowel disorders, obesity and other diseases (LeBlanc et al.,
2017; Ríos-Covián et al., 2016). Therefore, studies to select probiotics
with an enhanced ability to produce SCFA are relevant.
In addition to probiotic characteristics, it also desirable that these
microorganisms are adapted to the fermentation process and storage.
Probiotic products should be consumed regularly with an approximate
amount of 100 g/day to deliver about 109 viable cells into the intestine
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in order to positively influence consumer health (Tripathi & Giri, 2014).
Cheese is an excellent food matrix to transport probiotic, due to its
specific physical and chemical characteristics, such as pH between 5
and 6, high fat content and nutrient availability, and low oxygen con-
tent. Since these conditions favour their survival through gastro-
intestinal transit, the application of probiotics has been optimised in
different types of cheeses (Albenzio et al., 2013; Minervini et al., 2012).
Therefore, this study aimed to evaluate probiotic properties and pre-
biotic metabolism of autochthonous LAB isolated from artisanal Serpa
cheese, for potential application during its manufacturing process.
2. Material and methods
2.1. Bacterial isolates
A total of 116 LAB belonging to the Lactobacillus, Lactococcus,
Leuconostoc and Enterococcus genera, isolated from Serpa cheese
(Gonçalves et al., 2017), were selected to study their probiotic char-
acteristics (Table 1). LAB were routinely grown in de Man–Rogosa–-
Sharpe (MRS; Scharlab, Barcelona, Spain) broth at 37 °C under 10%
CO2 for 24 h. All strains were sub-cultured twice before the experi-
ments, harvested at 21,500×g for 5min at room temperature, washed
twice with phosphate-buffered saline (PBS; Thermo Fisher Scientific,
Waltham, MA, USA) at pH 7.2, and the cell concentration adjusted to
around 108 cfu mL−1. For all strains, three biological replicates of the
cultures and duplicate assays were conducted.
2.2. Probiotic assays in vitro
2.2.1. Tolerance to simulated GIT
To evaluate the acid tolerance of the LAB in vitro, they were exposed
to a pH between 2.5 and 3.0 for 2 h. Each isolate was incubated for 2 h
in PBS supplemented with 3.5 g L−1 of pepsin, and the pH adjusted to
2.5, 2.75, 3.0 or 5.0 (positive control) and measured by counting fol-
lowing the method described by Ruiz-Moyano, Martín, Benito, Nevado,
and Córdoba (2008).
The strains resistant to low pH were used to determine the survival
during complete gastrointestinal transit, by the method of Bao et al.
(2010). Briefly, 30 μL of concentrated strains were inoculated in 270 μL
of simulated gastric fluid (3.5 g L−1 porcine pepsin (≥400Units/mg
protein) and 2 g L−1 NaCl) at pH 2.75 for 2 h. Then 30 μL were transfer
to 270 μL of in simulated intestinal fluid (1 g L−1 trypsin, 5 g L−1 bile
salt, 2 g L−1 pancreatin [all from Sigma St. Louis, MO, USA], 11 g L−1
NaHCO3 and 2 g L−1 NaCl) at pH 8 during 6 h. The 96 micro-well plates
were incubated at 37 °C under 10% CO2, and the viable bacteria were
counted on MRS media after 0, 2, 4 and 6 h. Data were expressed in Log
cfu mL−1 reduction with respect to the initial inoculum (Time 0 h: 8
Log cfu mL−1). Strains with viable counts below 2 log cfu mL−1 com-
pared with the initial inoculums were considered not resistant.
2.2.2. Aggregation activity
The specific cell–cell interactions were determined using the auto-
aggregation assay described by Xu, Jeong, Lee, and Ahn (2009). The
auto-aggregation was calculated using the following equation:
Auto-aggregation (%) = (1 – At/A0)× 100 (1)
where At represents absorbance at a determined interval (1 or 2 h); and
A0 represents the absorbance at the beginning of the assay (0 h).
2.2.3. Cell surface hydrophobicity
The cell surface hydrophobicity was determined as described Lee
and Puong (2002). The decreased absorbance in the aqueous phase was
taken as a measure of cell surface hydrophobicity, calculated using the
following equation:
Hydrophobicity (%)= [(A0 - A1)/A0]× 100 (2)




The selected acid-tolerant strains were tested for antibiotic sus-
ceptibility by the disc diffusion method according to the National
Committee for Clinical Laboratory Standards (NCCLS, 2012). Twelve
clinically important antibiotics (Oxoid, Basingstoke, England) were
used: ampicillin (10 μg), gentamicin (10 μg), kanamycin (30 μg), tri-
methoprim (5 μg), erythromycin (15 μg), tetracycline (30 μg), clin-
damycin (2 μg), chloramphenicol (30 μg), penicillin G (10 U), poly-
myxin B (300 U), nalidixic acid (30 μg) and vancomycin (30 μg). The
diameters of the inhibition zones were measured and the results in-
terpreted according to the criteria proposed by Charteris, Kelly, Morelli,
and Collins (1998).
2.3.2. Biogenic amine (BA) production
The capacity of selected strains to produce BA was determined by
the improved agar medium, as described by Bover-Cid and Holzapfel
(1999). Moreover, the amount and type of BA produced in the im-
proved medium (Bover-Cid & Holzapfel, 1999), without agar and con-
taining 0.25% of each precursor amino acid after incubation for 4 days
at 37 °C and 10% CO2 was measured by high-performance liquid
chromatography (HPLC)–electrospray ionisation (ESI)-mass spectro-
metry, according to the method described by Fernández et al. (2016).
BA in samples was distinguished by their mass spectrum and retention
time.
2.4. Growth on prebiotic
The LAB selected on the basis of their probiotic properties were
tested for growth in the presence of three commercial prebiotics; lac-
tulose (Sigma), short-chain fructooligosaccharide (FOS, Orafti® P95
with a degree of polymerisation (DP) 2–8, Beneo-Orafti, Belgium) and
long-chain inulin (Orafti® GR with DP 2–60 and average DP≥ 10,
Beneo-Orafti). Two μL of each LAB strain suspension was inoculated in
200 μL of semi-solid MRS medium containing 0.125 g L−1 agar, devoid
of glucose, and supplemented with 2 g L−1 of each sterile-filtered pre-
biotic, as the sole carbohydrate source. The positive control for growth
consisted of semi-solid MRS supplemented with 2 g L−1 glucose or
lactose, whereas the negative control was a carbohydrate-free semi-
solid MRS. The automated turbidimeter Bioscreen C Microbiology
reader (Labsystem, Helsinki, Finland) set up at 37 °C was used to
monitor the growth for 96 h by reading the optical density (OD) at
Table 1
Selected LAB isolates from Serpa cheese to study probiotic characteristics.
Selected LAB from Serpa cheese (Gonçalves et al., 2017)
Species Nº isolates Code of acid-tolerant strains
Lactobacillus casei/paracasei 34 V1LB8, A2Lb1
Lactobacillus plantarum 16 C1Lc12, G4Lb1, G2Lb12, B1Lb12,
G1Lb5, G2Lb9
Lactobacillus brevis 12 V1Lb10, B1Lb3, C1Lb21, B2Lb5
Lactobacillus curvatus 4 –
Lactobacillus crustorum 4 A3Lb18, V1Lb9
Lactobacillus coryniformi 2 –
Lactobacillus pentosus 2 G4Lb7
Leuconostoc mesenteroides 12 –
Lactococcus lactis 2 –
Enterococcus faecium 14 V2Lb3, A1Lb9, G1Et4
Enterococcus hirae 12 G3Et3
Enterococcus durans 2 G1Et3
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600 nm at regular intervals without shaking. The ability of each strain
to grow in the presence of different prebiotics was evaluated by com-
paring the OD at 600 nm of each carbohydrate with the value obtained
on glucose.
2.5. SCFA production
To determine the capacity to produce SCFA, selected LAB strains
were grown on modified MRS (mMRS) broth at 37 °C under 10% CO2
until stationary phase. The mMRS was formulated as commercial MRS
devoid of glucose and sodium acetate and supplemented with 2 g L−1 of
the carbohydrate source (glucose, lactose, lactulose, FOS or inulin). The
supernatants of the cultures were obtained by centrifugation of the
media at 8000×g for 5min before filtering through 0.22-μm filters
(Thermo Fisher Scientific).
The concentration of lactic acid (D- and L-isomers) in the super-
natant was quantified using the enzymatic kit K-DLATE (Megazyme,
Bray, Ireland) according to the manufacturer's instructions.
To measure the amount of SCFA, 800 μL of supernatant was mixed
with 100 μL of internal standard solution (2-ethyl butyric acid [Sigma]
at 5mM prepared in 12% formic acid) and 100 μL of meta-phosphoric
acid solution (16 g L−1). SCFA were extracted with 500 μL of diethyl
ether by vortexing for 1min and centrifugation at 17,000×g, 4 °C for
5min. One microlitre of the upper phase was injected into a gas chro-
matograph (model 4890 Series II; Hewlett-Packard, Palo Alto, CA, USA)
equipped with a split/split-less injector and a flame ionisation detector.
SCFA were separated on a Carbowax™ fused silica capillary column
(30m×0.25mm id; 0.25 μm film thickness; (Ohio Valley, Marietta,
OH, USA). The initial oven temperature was held at 80 °C for 2min, and
then increased to 200 °C at 20 °C min−1 and retained for 12min. The
injector and detector were set at 250 °C. The carrier gas was nitrogen at
1.8 mLmin−1. The individual SCFA were identified by comparison of
their retention times with those of reference standard mixtures (acetic
acid, propionic acid, butyric acid, isobutyric acid, valeric acid, iso-
valeric acid, hexanoic acid from Sigma Chemical Co., St Louis, MO,
USA). SCFA concentrations were calculated by using the peak area ratio
of the analyte to the internal standard (2-ethyl butyric acid), as detailed
by Brighenti (1997).
2.6. Statistical analysis
Auto-aggregating and hydrophobicity data were analysed by one-
way analysis of variance (ANOVA), and SCFA production by two-way
ANOVA, respectively, using SPSS for Windows 21.0 (SPSS, Inc.,
Chicago, IL, USA). The means were separated by Tukey's honestly sig-
nificant difference (HSD) test (p≤ 0.05).
3. Results and discussion
3.1. Tolerance to the GIT conditions
All LAB isolates tolerated pH 3.0. When the isolates were exposed to
pH 2.5, none survived at the levels required. At an intermediate pH
(2.75), 20 of the 116 strains exhibited satisfactory levels of viability
after exposure for 2 h (Table 2). Previous authors have reported that the
viability of LAB is dramatically affected at low pH, especially below pH
2.5 (Zoumpopoulou et al., 2018). The acid tolerance of LAB is strain
specific and mediated via several mechanisms, in particular, F0F1-AT-
Pase is an important element in the response and tolerance to low pH in
Lactobacillus spp. (Corcoran, Stanton, Fitzgerald, & Ross, 2005). In this
study, a pH value of 2.75 was found to be highly discriminating and
although the pH of the stomach during a meal is normally above this
value, this value was set in order to guarantee the viability of the po-
tential probiotic strains.
The acid-tolerant strains were subjected to in vitro digestion. Most of
the selected strains showed good survival to complete GIT transit
(Table 2). However, two of the twenty strains, Lb. casei/paracasei strains
V1Lb8 and A2Lb1, decreased their viability dramatically when they
were exposed to simulated gastric fluid at pH 2.75 for 90min, followed
by 120min in simulated intestinal fluid. These results are consistent
with those previously recovered from other probiotic in vitro testing
where most of the strains were more resistant to bile salts than low pH
(Han, Kong, Chen, Sun, & Zhang, 2017; Ruiz-Moyano et al., 2008;
Zoumpopoulou et al., 2018).
3.2. Capacity to colonise the intestine
The percentage of auto-aggregation after incubation for 1 and 2 h
are presented in Fig. 1A. In general, the values varied between 1.43 and
9.14% at 1 h, and 2.70–17.14% at 2 h, respectively. All strains in-
creased the auto-aggregation percentages with the incubation time, in
congruence with other researchers (García-Cayuela et al., 2014; Han
et al., 2017). Among strains, significant differences were observed
(p≤ 0.05). At 2 h, seven of the twenty strains, Lb. brevis C1Lb21 and
B2Lb5, Lb. crustorum A3Lb18, E. faecium V2Lb3, A1Lb9 and G1Et4, and
E. durans G1Et3, exhibited better auto-aggregation, with values over
12%, corresponding to a noteworthy capacity based upon previous
studies in LAB (García-Cayuela et al., 2014; Han et al., 2017).
There was high variability in the hydrophobicity capacity, which
ranged from 5.42 to 76.50% (Fig. 1B). Lb. brevis C1Lb21 exhibited the
highest hydrophobicity (76.50%). The results obtained for both cell
surface properties did not always show the same trend in each strain, as
already noted by García-Cayuela et al. (2014). Adhesion is a very
complex mechanism influenced by multiple factors. Auto-aggregation
capacity is afforded by complex physical and chemical interactions, as
well as being influenced by environmental conditions (Collado,




Nowadays, antibiotic resistance is considered a serious concern in
medicine. According to the European Food Safety Authority (EFSA),
intrinsic resistance in bacteria present a minimal risk for horizontal
spread whereas acquired resistance is considered a high risk (EFSA,
2012). The antibiotic susceptibility of selected LAB strains against 12
common antibiotics is shown in Table S1. All lactobacilli strains were
found susceptible or moderately susceptible to penicillin G, chlor-
amphenicol, erythromycin, tetracycline, ampicillin, gentamycin and
clindamycin. In addition, it was found resistance of 11 lactobacilli
strains to kanamycin, all Lb. brevis and Lb. casei/paracasei strains to
polymyxin B, and three strains, Lb. brevis B1Lb2, Lb. casei/paracasei
V1lb8 and A2Lb1, to trimethoprim. In general, although there may be
differences between species and strains, most Lactobacillus spp. are
considered to be naturally resistant to vancomycin, nalidixic acid, ka-
namycin, polymyxin B and trimethoprim. In this context, the observed
patterns of antibiotic susceptibility agree with the results obtained in
the literature for these lactobacilli species, and they can be used in
fermented food (Abriouel et al., 2015). The resistance profiles of en-
terococci from food or clinical isolates vary widely, containing many
acquired traits. Enterococci are naturally resistant to cephalosporins,
low level aminoglycosides (kanamycin and gentamycin), polymixins,
lincomycin, clindamycin and often quinolones (nalidixic acid) (Sharma,
Tomar, Goswami, Sangwan, & Singh, 2014). The major concern was the
detection of acquired resistance to trimethoprim in three enterococci
strains, G3Et3, A1Lb9 and V2Lb3, and especially to relevant clinical
antibiotics, such as tetracycline (in two strains, A1Lb9 and G3Et3) and
vancomycin (in G1Et4). Consequently, these enterococci strains were
not selected.
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3.3.2. BA production
The ability of the LAB strains to produce BA in vitro is presented in
Table S2. Of the 20 strains, three Lactobacillus spp. (Lb. brevis B1Lb3 and
B2Lb5, and Lb. crustorum V1Lb9) and the five Enterococcus spp. strains
were positive on the decarboxylase medium. The HPLC-MS analysis
confirmed that all positive strains produced levels ranged from 523.61
to 4167.67mg L−1 of tyramine and tryptamine between 1.58 and
14.46mg L−1. Production of BA by potential probiotics strains is not a
desirable property due to its toxic effect on consumer health (Gardini,
Özogul, Suzzi, Tabanelli, & Özogul, 2016). So, the eight positive BA
amine strains were not suitable as probiotic candidate.
3.4. Prebiotic growth and SCFA production
The capacity of the 12 pre-selected LAB to grow in vitro on three
commercial prebiotics and positive substrate controls (glucose and
lactose) is showed in Fig. S1.
In general, all LAB strains reached a maximum OD 600 nm values in
lactulose comparable to the positive controls, although Lb. brevis
C1Lb21 and V1Lb10 presented a slower growth rate and a longer lag
phase. In the FOS or inulin, the growth was lower and more variable
between strains than in lactulose. Interestingly, Lb. casei/paracasei
V1Lb8 showed relevant growth on FOS and inulin while intermediate
growth was observed in the remaining strains, except for Lb. brevis
strains Lb. plantarum B2Lb1 and Lb. crustorum A3Lb18, which showed
low ability to use these prebiotics (Fig. S1). Contrary to the expected,
LAB growth was, generally, greater with inulin than FOS, despite the
higher DP of inulin. We suppose that this result might be influenced by
the relatively higher purity of FOS (Orafti® P95). The capacity to fer-
ment lactulose is widespread between lactobacilli species, and β-ga-
lactosidase activity has been related to lactulose hydrolysis and meta-
bolisation (Mao et al., 2014; Sharma & Kanwar, 2018). However, FOS
utilisation is generally more specific. Our results suggest that lactulose
is a suitable prebiotic to support lactobacilli growth. In addition, this
prebiotic has demonstrated to be selective to avoid pathogenic bacterial
growth (Sharma & Kanwar, 2018), improve the response of probiotics
to acid and bile stresses (Adebola, Corcoran, & Morgan, 2014) and exert
a positive effect in the treatment of intestinal disorders (Gibson,
Probert, Van Loo, Rastall, & Roberfroid, 2004; Vilela, Torres, Ferrari,
Lima, & Cunha, 2008).
Table 3 shows lactic acid and SCFA production by carbon source
obtained from the mean values of the 12 selected strains. Overall, lactic
acid was the principal metabolite detected ranged from 15.086mM in
FOS to 120.697mM in lactose. The acetic acid ranged from 6.500mM
in FOS to15.471 in lactulose. Small amounts of butyric, isobutyric,
propionic and isovaleric acids were detected. The limited capacity of
most of the LAB strains to ferment FOS and inulin was evidenced by the
low lactic acid and SCFA production. Interestingly, lactulose statisti-
cally increased the production of SCFA and induced a noteworthy level
of lactic acid, plus a lower ratio of D-lactic acid, which has been asso-
ciated with potential health problems. SCFA display distinct positive
physiological effects on the host. Butyric acid has been the most widely
studied for its anti-carcinogenic and anti-inflammatory effects, al-
though acetic acid and propionic acid also exhibit health-promoting
actions (Russell, Hoyles, Flint, & Dumas, 2013).
Regarding the strain capacity, Fig. 2 shows the mean values and
statistical differences between the organic acids produced by the pre-
selected LAB strains in lactulose and carbohydrate source controls.
Significant differences (p≤ 0.05) were found between strains in the
amount of SCFA produced in lactulose. For all tested strains, acetic acid
was the second major metabolite, with approximately 10-fold less
concentration than lactic acid, except for Lb. pentosus G4Lb7 that pro-
duced a similar amount of both metabolites. For the remaining com-
pounds detected, the concentrations were approximately similar to
each other, with values around 0.10mM. Besides acetic acid, Lb. pen-
tosus G4Lb7 also produced significantly higher (p≤ 0.05) amounts of
butyric, isobutyric, propionic and isovaleric acids while similar patterns
were found among the other strains. Among them, Lb. casei/paracasei
A2Lb1 stood out due to its high production of propionic acid compar-
able to Lb. pentosus G4Lb7, and slightly higher than average amount of
the other SCFA, although this strain was not resistant to GIT transit
(Table 2).
With respect to lactic acid production in lactose and glucose, Lb.
plantarum G2Lb9 produced the highest amounts (p≤ 0.05), with values
around 175mM, followed by a second group of strains composed of Lb.
plantarum G1Lb5, C1Lc12 and G4Lb7, Lb. casei/paracasei V1Lb8 and Lb.
pentosus G4Lb7, with values ranging from 130 to 155mM. Lactic acid
production from lactose fermentation by cheese microbiota has
Table 2
Tolerance of bacterial strains to low pH, and complete gastrointestinal transit. Data are expressed in Log cfu mL−1 reduction with respect to the initial inoculum
(Time 0 h: 8 Log cfu mL−1).
LAB strains pH tolerance (2.75) Tolerance to gastointestinal transit
Gastric juice (pH2.75) 1.5 h Intestinal juice
1 h 1.5 h 2 h 2 h 4 h 6 h
Lb. plantarum C1Lc12 0 0 0 0 1 1 1
G4Lb1 1 1 2 0 0 0 0
G2Lb12 0 1 1 0 0 0 0
B1Lb2 0 1 1 1 1 1 2
G1Lb5 1 1 1 0 0 0 0
G2Lb9 1 1 2 1 1 1 1
Lb. brevis V1Lb10 0 1 1 1 2 2 3
B1Lb3 1 1 1 0 0 0 0
C1Lb21 0 0 0 0 1 1 1
B2Lb5 0 0 1 0 1 1 1
Lb. casei/paracasei V1Lb8 1 2 2 2 3 5 8
A2Lb1 1 1 1 1 3 4 7
Lb. crustorum A3Lb18 0 1 1 0 0 1 1
V1Lb9 0 1 1 0 0 0 0
Lb. pentosus G4Lb7 1 1 2 1 1 1 1
E. faecium V2Lb3 0 1 1 0 0 0 0
A1Lb9 1 1 1 1 1 1 1
G1Et4 0 0 0 0 0 0 1
E. durans G1Et3 0 0 0 0 0 0 0
E. hirae G3Et3 0 0 0 0 0 0 0
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Fig. 1. (A) Auto-aggregation percentages of LAB strains after 1 h (grey bars) and 2 h (white bars) and (B) hydrophobicity capacity against hexadecane. SSB: statistical
significance bar using Tukey's HSD test (p≤ 0.05).
Table 3
Amount of lactic acid and short-chain fatty acids (SCFA) by carbohydrate source. Each data is the average values obtained from the 12 selected strains.
Carbon source Organic acids (mM)
Lactic acid L-lactic acid D-lactic acetic Propionic butyric Isobutyric Isovaleric
Lactose Mean 120.697a* 63.596b 57.100a 7.098b 0.057b 0.0788b 0.051b 0.037b
Std. Deviation 29.517 21.410 34.518 3.990 0.010 0.007 0.014 0.008
Glucose Mean 116.335b 72.204a 44.130b 6.503b 0.053b 0.079b 0.047b 0.038b
Std. Deviation 32.863 26.865 27.845 3.647 0.011 0.012 0.007 0.006
Lactulose Mean 92.016c 62.866b 29.149c 15.471a 0.130a 0.113a 0.080a 0.055a
Std. Deviation 31.265 28.650 20.246 4.699 0.078 0.045 0.051 0.021
Inulin Mean 21.590d 15.192c 6.398d 6.708b 0.049c 0.060c 0.038c 0.030c
Std. Deviation 30.778 28.255 6.770 5.322 0.048 0.044 0.038 0.022
FOS Mean 15.086e 12.999c 2.086e 6.500b 0.041c 0.058c 0.036c 0.027c
Std. Deviation 32.633 32.187 1.843 5.551 0.030 0.042 0.037 0.020
P≤ 0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tukey HSD IC ±4.174 ±3.158 ±2.630 ±1.299 ±0.009 ±0.006 ±0.007 ±0.005
* a,b,c,d,e For a given organic acid, values (column) with different superscript letters are significantly different (p≤ 0.05).
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technological applications during cheese ripening, to drop the pH and
provide an acidic environment, which, in turn, ensures food safety and
favours the coagulation process (McSweeney, 2004). In lactulose, Lb.
plantarum G1Lb5 produced the greatest amounts of lactic acid
(p≤ 0.05), reaching levels of 153mM, without statistical difference
from glucose and lactose. The other strains, except for the two Lb. casei/
paracasei, exhibited an evident decrease in the production of this me-
tabolite. Lactulose is not consumed in the upper part of the intestine
and can stimulate the growth of probiotics in the colon and lactic acid
production. Although, in general, LAB produced low amounts of the
most interesting SCFA for human health, it must be considered that a
potential probiotic will be a member of the intestinal microbiota where
it may establish possible cross-feeding interactions with lactate-con-
suming butyrate-producing colon bacteria (Moens, Verce, & De Vuyst,
2017). Thus, to select a potential probiotic, aside from SCFA production
capacity in assay conditions, it is also relevant to consider their ability
to produce lactic acid from non-digestible oligosaccharides, as this may
contribute to increasing the daily SCFA amount in the colon environ-
ment, by the activity of the intestinal microbiota.
In conclusion, considering their tolerance to gastrointestinal transit,
capacity to colonise the intestine, safety properties and prebiotics me-
tabolism, Lb. brevis C1Lb21, Lb. plantarum G1Lb5 and Lb. pentosus
G4Lb7 are promising candidates for their use in a new functional
cheese. The development of a symbiotic commercial cheese with lac-
tulose prebiotic to support LAB growth and induce SCFA production
could positively impact on human health.
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